Charles Harris, NP
Nurse Practitioner · Boone, NCNPI 1831581404
Payments from drug & device makers
Across 167 payments — averaging $15.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$846
- Gilead$483
- GSK$236
- Lilly USA, LLC$190
- Takeda Pharmaceuticals U.S.A., Inc.$116
- Abbott$116
- plus $573 from 14 others
What the payments were for
- Food & beverage$2,558100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 70 | $846 |
| Gilead | 25 | $483 |
| GSK | 13 | $236 |
| Lilly USA, LLC | 13 | $190 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $116 |
| Abbott | 5 | $116 |
| Amgen | 6 | $97 |
| AstraZeneca | 5 | $75 |
| Novo Nordisk | 5 | $73 |
| Dexcom, Inc. | 3 | $60 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $50 |
| Exact Sciences | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Pfizer | 2 | $27 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $27 |
| Mylan Specialty L.p. | 1 | $21 |
| Indivior Inc. | 1 | $21 |
| Si-bone, Inc. | 1 | $20 |
| Novartis | 1 | $15 |
| Nestle Healthcare Nutrition Inc. | 1 | $11 |
How this compares
$2,558 in reported general payments places this provider in the 85th percentile of 4,393 nurse practitioner providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 71 | $96,486 |
| EliquisApixaban | 74 | $62,881 |
| TrulicityDulaglutide | 49 | $56,060 |
| OzempicSemaglutide | 25 | $32,077 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 25 | $27,919 |
| VraylarCariprazine Hcl | 12 | $22,037 |
| FarxigaDapagliflozin Propanediol | 21 | $17,900 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 22 | $17,325 |
| Tresiba Flextouch U-200Insulin Degludec | 13 | $15,354 |
| LinzessLinaclotide | 17 | $14,158 |
| Spiriva HandihalerTiotropium Bromide | 17 | $11,664 |
| EntrestoSacubitril/Valsartan | 12 | $7,302 |
| Gabapentin | 335 | $6,759 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 12 | $6,374 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $5,859 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $190 | $152,545120 claims |
| PfizerEliquis, Paxlovid | $27 | $64,31086 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $75 | $41,08455 claims |
| AbbVieVraylar, Linzess, Synthroid | $846 | $38,25567 claims |
| Novo NordiskOzempic | $73 | $32,07725 claims |
| GSKTrelegy Ellipta | $236 | $27,91925 claims |
| NovartisEntresto | $15 | $7,30212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,393 nurse practitioner providers in North Carolina.
Other nurse practitioner in Boone
- Sandrivette JohnsonRaleigh$573K
- Skyler RogersPinehurst$174K
- Jamie DinerDurham$170K
- Ayeshia WrightMocksville$145K
- Deborah AllenDurham$112K
- Jeanann VawterGastonia$97K
- Terra KampJacksonville$72K
- Mary DilorenzoCharlotte$71K
- Olivia OgburnWinston Salem$70K
- Bridget ArchambaultDurham$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.